Till Braun

Kerpener Str. 62
Koeln, NW 50937, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications

The expanding spectrum of CAR-T related T-cell lymphomas.

The expanding spectrum of CAR-T related T-cell lymphomas.

Journal: Haematologica
Published: February 19, 2026

Characteristics, patterns of care and outcomes of patients with T-cell lymphoma-associated hemophagocytic lymphohistiocytosis: a single-center retrospective analysis.

Characteristics, patterns of care and outcomes of patients with T-cell lymphoma-associated hemophagocytic lymphohistiocytosis: a single-center retrospective analysis.

Journal: Leukemia & lymphoma
Published: December 05, 2025

Reshaping the TME to enhance checkpoint blockade in ENKTL.

Reshaping the TME to enhance checkpoint blockade in ENKTL.

Journal: Blood
Published: July 10, 2025

International Consensus Criteria for the Diagnosis, Treatment Initiation, and Response Assessment for T-LGL Leukemia.

International Consensus Criteria for the Diagnosis, Treatment Initiation, and Response Assessment for T-LGL Leukemia.

Journal: Blood
Published: June 25, 2025

Comparative preclinical drug response analyses of T-prolymphocytic leukemia reveal no differences between known gene expression subgroups.

Comparative preclinical drug response analyses of T-prolymphocytic leukemia reveal no differences between known gene expression subgroups.

Journal: Biology direct
Published: May 12, 2025

Multiomics Profiling of T-cell Leukemia and Lymphoma Enables Targeted Therapeutic Discovery.

Multiomics Profiling of T-cell Leukemia and Lymphoma Enables Targeted Therapeutic Discovery.

Journal: Cancer research
Published: February 27, 2025

Emerging T-cell lymphomas after CAR T-cell therapy.

Emerging T-cell lymphomas after CAR T-cell therapy.

Journal: Leukemia
Published: February 19, 2025

Dual STAT3/STAT5 inhibition as a novel treatment strategy in T-prolymphocytic leukemia.

Dual STAT3/STAT5 inhibition as a novel treatment strategy in T-prolymphocytic leukemia.

Journal: Leukemia
Published: January 10, 2025

Models for T-large granular lymphocytic leukemia: how to mimic the cellular interplays in malignant autoimmunity.

Models for T-large granular lymphocytic leukemia: how to mimic the cellular interplays in malignant autoimmunity.

Journal: Leukemia
Published: December 18, 2024

Discovery of molecularly-informed therapeutic strategies for mature T-cell leukemias and lymphomas.

Discovery of molecularly-informed therapeutic strategies for mature T-cell leukemias and lymphomas.

Journal: Blood advances
Published: October 23, 2024

Multiomic profiling of T cell lymphoma after therapy with anti-BCMA CAR T cells and GPRC5D-directed bispecific antibody.

Multiomic profiling of T cell lymphoma after therapy with anti-BCMA CAR T cells and GPRC5D-directed bispecific antibody.

Journal: Nature medicine
Published: October 20, 2024

Post-transplant-cyclophosphamide plus everolimus as GvHD prophylaxis in refractory T- and B-cell lymphoma.

Post-transplant-cyclophosphamide plus everolimus as GvHD prophylaxis in refractory T- and B-cell lymphoma.

Journal: Bone marrow transplantation
Published: July 16, 2024
Showing 1-12 of 30

Last Updated: 09/26/2026